Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell...

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )

COVID-19: Treating breast cancer and the knock on effects of the coronavirus...

Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK

COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic ( Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK )

Do immune checkpoint inhibitors work in EGFR mutant lung cancer?

Dr Edward Garon - UCLA Medical Center, Santa Monica, USA

Do immune checkpoint inhibitors work in EGFR mutant lung cancer? ( Dr Edward Garon - UCLA Medical Center, Santa Monica, USA )

IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator...

Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA

IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imprime PGG, in second-line mTNBC ( Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA )

Gynaecological cancers in the era of fertility preservation

Dr Fedro Peccatori - European Institute of Oncology, Milan, Italy

Gynaecological cancers in the era of fertility preservation ( Dr Fedro Peccatori - European Institute of Oncology, Milan, Italy )

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk...

Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer ( Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA )

Using cancer research strategies to develop an anti-coronavirus vaccine

Dr Bernard Fox - Providence Cancer Institute, Portland, USA

Using cancer research strategies to develop an anti-coronavirus vaccine ( Dr Bernard Fox - Providence Cancer Institute, Portland, USA )

Managing Hodgkin lymphoma during the COVID-19 outbreak

Dr Anna Sureda - Hospitalet de Llobregat, Barcelona, Spain

Managing Hodgkin lymphoma during the COVID-19 outbreak ( Dr Anna Sureda - Hospitalet de Llobregat, Barcelona, Spain )

CARTs for the treatment of T-cell malignancies

Dr John DiPersio - Siteman Cancer Center, St. Louis, USA

CARTs for the treatment of T-cell malignancies ( Dr John DiPersio - Siteman Cancer Center, St. Louis, USA )

EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or...

Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA

EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma ( Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )

KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC

Dr Julie Graff - Oregon Health & Science University, Portland, USA

KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC ( Dr Julie Graff - Oregon Health & Science University, Portland, USA )

BCG dosing for bladder cancer: Standard frequency schedule correct

Prof Oliver Grimm - Universitätsklinikum Jena, Jena, Germany

BCG dosing for bladder cancer: Standard frequency schedule correct ( Prof Oliver Grimm - Universitätsklinikum Jena, Jena, Germany )

More from ecancer